Sign In

Login

Password

Forgot Password ? Sign Up

Hiperplàsia benigna de pròstata (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hiperplàsia benigna de pròstata" in Catalan language version.

refsWebsite
Global rank Catalan rank
17nih.gov
4th place
7th place
7doi.org
2nd place
6th place
1worldcat.org
5th place
5th place
1jamanetwork.com
2,650th place
3,376th place
1aemps.gob.es
low place
932nd place
1nejm.org
2,374th place
2,440th place

aemps.gob.es

doi.org

dx.doi.org

jamanetwork.com

nejm.org

nih.gov

ncbi.nlm.nih.gov

  • Barry MJ, Fowler FJ Jr, O'Leary MP, et al (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148(5): 1549-57. PMID: 1279218
  • Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. «Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010». Lancet, 380, 9859, 2012, pàg. 2163-96. DOI: 10.1016/S0140-6736(12)61729-2. PMC: 6350784. PMID: 23245607 [Consulta: 10 febrer 2023].
  • Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM et al. «Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound.». Urology, 49, 4, 1997, pàg. 548-57. PMID: 9111624.
  • Bosch JL, Bohnen AM, Groeneveld FP «Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study.». Eur Urol, 46, 6, 2004, pàg. 753-9. DOI: 10.1016/j.eururo.2004.07.019. PMID: 15548443.
  • Roehrborn, CG «Accurate determination of prostate size via digital rectal examination and transrectal ultrasound». Urology, 51, 4, 1998, pàg. 19-22. PMID: 9586592.
  • McNeill SA, Hargreave TB, Geffriaud-Ricouard C, Santoni J, Roehrborn CG «Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.». Urology, 57, 3, 2001, pàg. 459-65. PMID: 11248620.
  • «Improving ultrasound-based prostate volume estimation». BMC Urology, 19, 1, juliol 2019, pàg. 68. DOI: 10.1186/s12894-019-0492-2. PMC: 6657110. PMID: 31340802.
  • Nickel JC, Sander S, Moon TD «A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.». Int J Clin Pract, 62, 10, 2008, pàg. 1547-59. DOI: 10.1111/j.1742-1241.2008.01880.x. PMC: 2658011. PMID: 18822025.
  • Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z «Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.». JAMA, 296, 19, 2006, pàg. 2319-28. DOI: 10.1001/jama.296.19.2319. PMID: 17105794 [Consulta: 29 gener 2023].
  • AUA Practice Guidelines Committee.AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis y recomendaciones de tratamientos. J Urol 170(2 Pt 1): 530-47. PMID: 12853821
  • Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD et al. «The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.». N Engl J Med, 327, 17, 1992, pàg. 1185-91. PMID: 1383816 [Consulta: 29 gener 2023].
  • Kaplan SA, McConnell JD, Roehrborn CG, et al (2006). Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. J Urol 175(1): 217-20. PMID: 16406915
  • Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ «Finasteride for benign prostatic hyperplasia». Cochrane Database Syst Rev, 10, 2010. DOI: 10.1002/14651858.CD006015.pub3. PMID: 20927745.
  • McVary KT, Monnig W, Camps JL Jr, et al (2007). Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177(3) :1071-7. PMID: 17296414
  • Wilt TJ, Ishani A, MacDonald R, (2002). Serenoa repens for benign prostatic hyperplasia. Cochrane Library Database Syst Rev 2002 (3), CD001423. (Medline abstract)
  • Wilt TJ, Ishani A, Rutks I, MacDonald R. 2000. Fitoterapia para hiperplasia benigna de próstata, Public Health Nutr. 3(4A):459-72 (Medline abstract)
  • Buck AC, Cox R, Rees RWM, et al. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, Cernilton. A double-blind placebo-controlled study Br. J. Urol. 66:398-404 (1990) (Medline abstract)

worldcat.org